Hims & Hers Health (HIMS) Payables (2019 - 2026)
Hims & Hers Health (HIMS) posted Payables of $306.9 million for Q1 2026, up 114.17% sequentially from $143.3 million in Q4 2025, and up 181.74% YoY from $108.9 million in Q1 2025.
Hims & Hers Health (HIMS) Payables (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Payables for 8 years, with the latest figure at $306.9 million in Q1 2026.
- Quarterly Payables rose 181.74% year-over-year to $306.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $306.9 million (up 181.74% YoY) and the FY2025 annual result came in at $143.3 million, up 57.14% from the prior year.
- Payables advanced to $306.9 million in Q1 2026 per HIMS's latest filing, from $143.3 million in the prior quarter.
- Over five years, Payables peaked at $306.9 million in Q1 2026 and troughed at $23.9 million in Q1 2022.
- A 5-year average of $82.8 million and a median of $43.9 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2024 and 2026: Payables climbed 16.78% in 2024, then soared 181.74% in 2026.
- Over 5 years, Payables stood at $32.4 million in 2022, then jumped by 33.08% to $43.1 million in 2023, then jumped by 111.7% to $91.2 million in 2024, then jumped by 57.14% to $143.3 million in 2025, then soared by 114.17% to $306.9 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $306.9 million, $143.3 million, and $198.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -7.73 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 2.72 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 673.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 2.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 497.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.73 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 808.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 427.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 986.00 Mn |
| 10 | Hims & Hers Health | 7.42 Bn | 6.57 Bn | 480.80 Mn | 501.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 501.30 Mn |
| Mar 31, 2026 | 306.87 Mn |
| Dec 31, 2025 | 143.28 Mn |
| Sep 30, 2025 | 198.41 Mn |
| Jun 30, 2025 | 105.01 Mn |
| Mar 31, 2025 | 108.92 Mn |
| Dec 31, 2024 | 91.18 Mn |
| Sep 30, 2024 | 75.44 Mn |
| Jun 30, 2024 | 57.10 Mn |
| Mar 31, 2024 | 43.92 Mn |
| Dec 31, 2023 | 43.07 Mn |
| Sep 30, 2023 | 42.00 Mn |
| Jun 30, 2023 | 38.27 Mn |
| Mar 31, 2023 | 37.61 Mn |
| Dec 31, 2022 | 32.36 Mn |
| Sep 30, 2022 | 32.97 Mn |
| Jun 30, 2022 | 27.09 Mn |
| Mar 31, 2022 | 23.91 Mn |
| Dec 31, 2021 | 19.64 Mn |
| Sep 30, 2021 | 16.09 Mn |